Menu
ncarol.com
  • Home
  • Education
  • Financial
  • Health
  • Real Estate
  • Technology
  • Business
  • Entertainment
  • Music
ncarol.com

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
ncarol.com/10291348

Trending...
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • Special Alert! Highly Undervalued Stock: $317M Revenue in 2025 for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - ncarol.com -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on ncarol.com
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
  • Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
  • Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
  • Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
  • Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
  • BumblebeeSmart Introduces Extra Large Mountain-Themed Sensory Wall Panels Set for Schools, Clinics and Family Spaces
  • All American Home Renovators: Transforming Bathrooms into Masterpieces, One Home at a Time
  • Bold Beauty Project Celebrates Anniversary with Collaborative Exhibition at FIU's Miami Beach Urban Studios
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
  • Bold Beauty Project Announces Exhibition at Palazzo Mora Venice, Italy
  • Financial Educator Jessica Perrone Launches Free "3 Stages of Building Wealth" Course for Women
  • Captain Notepad Expands Free Custom Design Services Across Full Product Line
  • Lake Norman Philharmonic - Free Spring Concert
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
  • Floor Kings Announces Official Launch of Premier Epoxy Flooring Services Across Arizona
  • STEM For Kids and Operation Xcel Partner to Drive Student Success Through Innovative STEM Pilot
  • UK Buyers Purchase Luxury Home in Keene's Pointe, Windermere (Orlando, Florida)
  • Instant IP Launches Rapid Takedown Service to Combat IP Theft, Deepfakes, and Copycat Websites
  • Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
  • This Saturday: Open House for Manalapan's Newest Single Family Home Community
_catLbl0 _catLbl1

Popular on ncarol.com

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 291
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets - 123
  • Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago - 108
  • Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
  • Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • U.S. Government Contracts in Excess of 38 Million Secured Through Partner, Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
  • $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
  • Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
  • Shincheonji Marks 42nd Anniversary: From a Basement to a Denomination Growing by Tens of Thousands Annually

Similar on ncarol.com

  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • Nufabrx Announces Strategic Acquisition of Elos Thermal
  • CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
  • Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
  • BumblebeeSmart Introduces Extra Large Mountain-Themed Sensory Wall Panels Set for Schools, Clinics and Family Spaces
  • All American Home Renovators: Transforming Bathrooms into Masterpieces, One Home at a Time
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
  • Bold Beauty Project Announces Exhibition at Palazzo Mora Venice, Italy
  • Financial Educator Jessica Perrone Launches Free "3 Stages of Building Wealth" Course for Women
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute